IXHL vs JAGX

Incannex Healthcare Inc. vs Jaguar Health, Inc. — Valuation Comparison 2026

IXHL

Pharmaceutical Preparations
Incannex Healthcare Inc.
Quality
5.3
out of 10
Value Trap
12
SAFE
Price
$3.35
Last close
Models
9/13
Active
VS

JAGX

Pharmaceutical Preparations
Jaguar Health, Inc.
Quality
4.2
out of 10
Value Trap
47
WARN
Price
$3.55
Last close
Models
4/13
Active

Model-by-Model Comparison

ModelType IXHL Fair ValueIXHL Upside JAGX Fair ValueJAGX Upside
Bayesian DCF Intrinsic $4.37 +30.4%
First Chicago Scenario $5.42 +49.0% $4.44 +27.9%
ML-RIV Intrinsic $2.50 -25.3% $0.66 -90.2%
Dynamic NAV Asset-Based $6.70 +100.1%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for IXHL vs JAGX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

IXHL vs JAGX — Which Stock Is More Undervalued?

IXHL scores higher with a 5.3/10 quality rating vs JAGX's 4.2/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Incannex Healthcare Inc. (IXHL) and Jaguar Health, Inc. (JAGX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

IXHL currently trades at $3.35 with a QOC of 5.3/10, while JAGX trades at $3.55 with a QOC of 4.2/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).